Vulvodynia

TOPIC/TITLE OF PRESENTATION:  Vulvodynia
                                                            
SPEAKER NAME(S):  David Foster, MD, MPH & Megan Falsetta, PhD                              

ACADEMIC TITLE/AFFILIATION:  Vulvodynia
                                                          University of Rochester
                                                          Dept of Obstetrics and Gynecology
                                                  
LEARNING OBJECTIVE(S):              At the conclusion of this session, the learner should be able to:  

                                                         1.  Recognize the condition of vulvodynia, enumerate risk factors, describe proposed
                                                              neuroinflammatory etiology.
                                                         2.  Understand the in vitro model and preclinical model and how these may help to identify
                                                               novel therapeutics.   
                                                          3.  Recognize and discuss the underlying inflammatory causes of localized provoked vulvodynia.
                                                          4.  Understand how knowledge of these underlying causes can be used to imrpove therapeutic
                                                               approaches for vulvodynia, without necessarily replacing or dramatically altering current
                                                               standards of treatment.
                                                                        
Planning Committee and Speaker Declarations:  The Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support requires that presentations are free of commercial bias and that any information regarding commercial products/services be based on scientific methods generally accepted by the medical community. The following speaker(s) have disclosed financial interest/arrangements or affiliations with organization(s) that could be perceived as a real or apparent conflict of interest in the context of the subject of their presentation(s).  Only the current arrangements/interests are included.

PLANNING COMMITTEE AND SPEAKER NAME(S):                  
DECLARATIONS (if none, state “none):          none                                       

Eva K. Pressman, M.D. (Activity Director)      none                                   

COMMERCIAL SUPPORTER FOR THIS SESSION (if none, state “none):    none        

ACCREDITATION: The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CERTIFICATION: The University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Question Title

* 2. If yes, please explain

Question Title

* 3. What was the key “take away” message from this presentation?

Question Title

* 4. Please add any comments or suggestions you have regarding this presentation.

Question Title

* 5. Please suggest any future topics you would like to see presented or ideas on how the sessions could be improved.

Question Title

* 6. Please enter your first name to receive CME credit.

Question Title

* 7. Please enter your last name to receive CME credit.

Question Title

* 8. Please enter your birth month and day to receive CME credit. Format mm/dd

ACCME Standards of Commercial Support of CME require that presentations be free of commercial bias and that any information regarding commercial products/services be based on scientific methods generally accepted by the medical community.  When discussing therapeutic options, faculty are requested to use only generic names.  If they use a trade name, then those of several companies should be used.  If a presentation includes discussion of any unlabelled or investigational use of a commercial product, faculty are required to disclose this to the participants.

T